European Union Trademark Granted for Tauri-Gum (Valid Thru Year 2029)
European Union Trademark Granted for Tauri-Gummies (Valid Thru Year 2029)
Pharmaceutical Grade Proposed “Anti-Nausea” Version of Tauri-Gum (Indication: Nausea Derived from Ongoing Chemotherapy Treatment)
Assignment of U.S. Provisional Patent to Tauriga Sciences Inc.
